Literature DB >> 18458778

Inclusion of cognitive impairment in the DSM diagnosis of schizophrenia: if not now, when?

Siow-Ann Chong1.   

Abstract

Entities:  

Year:  2008        PMID: 18458778      PMCID: PMC2327236          DOI: 10.1002/j.2051-5545.2008.tb00150.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  15 in total

1.  Beyond clinical utility: broadening the DSM-V research appendix to include alternative diagnostic constructs.

Authors:  Michael B First
Journal:  Am J Psychiatry       Date:  2006-10       Impact factor: 18.112

2.  Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study.

Authors:  Gary Donohoe; Derek W Morris; Sarah Clarke; Kevin A McGhee; Siobhan Schwaiger; Jeanne-Marie Nangle; Hugh Garavan; Ian H Robertson; Michael Gill; Aiden Corvin
Journal:  Neuropsychologia       Date:  2006-08-22       Impact factor: 3.139

3.  Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

Authors:  T W Weickert; T E Goldberg; J M Gold; L B Bigelow; M F Egan; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2000-09

4.  Schizophrenic patients without neuropsychological deficits: subgroup, disease severity or cognitive compensation?

Authors:  Esther A E Holthausen; Durk Wiersma; Margriet M Sitskoorn; Ron Hijman; Peter M Dingemans; Aart H Schene; Robert J van den Bosch
Journal:  Psychiatry Res       Date:  2002-09-15       Impact factor: 3.222

5.  Diagnostic categories or dimensions? A question for the Diagnostic And Statistical Manual Of Mental Disorders--fifth edition.

Authors:  Thomas A Widiger; Douglas B Samuel
Journal:  J Abnorm Psychol       Date:  2005-11

6.  Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.

Authors:  Stephen R Marder; Wayne Fenton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

7.  Cognitive heterogeneity in first-episode schizophrenia.

Authors:  Eileen M Joyce; Sam B Hutton; Stanley H Mutsatsa; Thomas R E Barnes
Journal:  Br J Psychiatry       Date:  2005-12       Impact factor: 9.319

8.  Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  D S Knopman; S T DeKosky; J L Cummings; H Chui; J Corey-Bloom; N Relkin; G W Small; B Miller; J C Stevens
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

9.  Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.

Authors:  Christopher R Bowie; Abraham Reichenberg; Thomas L Patterson; Robert K Heaton; Philip D Harvey
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  3 in total

Review 1.  Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

Authors:  Cassandra J Hatzipantelis; Monica Langiu; Teresa H Vandekolk; Tracie L Pierce; Jess Nithianantharajah; Gregory D Stewart; Christopher J Langmead
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-28

2.  Markers of neurodevelopmental impairments in early-onset psychosis.

Authors:  Maria Giuseppina Petruzzelli; Lucia Margari; Francesco Craig; Maria Gloria Campa; Domenico Martinelli; Adriana Pastore; Marta Simone; Francesco Margari
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-20       Impact factor: 2.570

3.  Working memory training in patients with chronic schizophrenia: a pilot study.

Authors:  Martina Hubacher; Marcus Weiland; Pasquale Calabrese; Gabriela Stoppe; Markus Stöcklin; David Fischer-Barnicol; Klaus Opwis; Iris-Katharina Penner
Journal:  Psychiatry J       Date:  2013-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.